These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34355533)

  • 1. The outcomes of thrombotic microangiopathy after liver transplantation: A nationwide survey in Japan.
    Takatsuki M; Eguchi S; Yamamoto M; Yamaue H; Takada Y;
    J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):282-292. PubMed ID: 34355533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic microangiopathy after living-donor liver transplantation.
    Shindoh J; Sugawara Y; Akamatsu N; Kaneko J; Tamura S; Yamashiki N; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N
    Am J Transplant; 2012 Mar; 12(3):728-36. PubMed ID: 22070669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.
    Hori T; Kaido T; Oike F; Ogura Y; Ogawa K; Yonekawa Y; Hata K; Kawaguchi Y; Ueda M; Mori A; Segawa H; Yurugi K; Takada Y; Egawa H; Yoshizawa A; Kato T; Saito K; Wang L; Torii M; Chen F; Baine AM; Gardner LB; Uemoto S
    World J Gastroenterol; 2011 Apr; 17(14):1848-57. PubMed ID: 21528059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide cross-sectional analysis of thrombotic microangiopathy in the Japan Renal Biopsy Registry (J-RBR).
    Katsuno T; Ito Y; Kagami S; Kitamura H; Maruyama S; Shimizu A; Sugiyama H; Sato H; Yokoyama H; Kashihara N
    Clin Exp Nephrol; 2020 Sep; 24(9):789-797. PubMed ID: 32415379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation.
    Kishida N; Shinoda M; Itano O; Obara H; Kitago M; Hibi T; Yagi H; Abe Y; Matsubara K; Odaira M; Tanabe M; Shimazu M; Kitagawa Y
    Ann Transplant; 2016 Dec; 21():755-764. PubMed ID: 27956735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy after living-donor liver re-transplantation.
    Matsusaki T; Morimatsu H; Sato T; Sato K; Mizobuchi S; Morita K
    J Anesth; 2010 Aug; 24(4):614-7. PubMed ID: 20458598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
    Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
    Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case.
    Matsuda D; Toshima T; Ikegami T; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Clin J Gastroenterol; 2014 Apr; 7(2):159-63. PubMed ID: 26183634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical-pathological correlations in post-transplant thrombotic microangiopathy.
    Broecker V; Bardsley V; Torpey N; Perera R; Montero R; Dorling A; Bentall A; Neil D; Willicombe M; Berry M; Roufosse C
    Histopathology; 2019 Jul; 75(1):88-103. PubMed ID: 30851188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Transplantation-Associated Thrombotic Microangiopathy (TA-TMA) and Comparison between Renal TA-TMA and Intestinal TA-TMA: Autopsy Study.
    Yamada R; Nemoto T; Ohashi K; Tonooka A; Horiguchi SI; Motoi T; Hishima T
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):178-188. PubMed ID: 31491486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
    El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy.
    Nishi H; Hanafusa N; Kondo Y; Nangaku M; Sugawara Y; Makuuchi M; Noiri E; Fujita T
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):811-9. PubMed ID: 17699291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.
    Motomura T; Yoshizumi T; Ohira M; Mano Y; Toshima T; Itoh S; Harada N; Harimoto N; Ikegami T; Soejima Y; Maehara Y
    Transplant Proc; 2017 Dec; 49(10):2409-2410. PubMed ID: 29198692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
    Jodele S; Laskin BL; Goebel J; Khoury JC; Pinkard SL; Carey PM; Davies SM
    Transfusion; 2013 Mar; 53(3):661-7. PubMed ID: 22804695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
    Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
    Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile and outcomes of
    Saikumar Doradla LP; Lal H; Kaul A; Bhaduaria D; Jain M; Prasad N; Thammishetti V; Gupta A; Patel M; Sharma RK
    Saudi J Kidney Dis Transpl; 2020; 31(1):160-168. PubMed ID: 32129209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.